Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.31 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.31 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3682642 | 0.85 | LMNA (0.47) | LMNAPOLBTDP1TSHRMEN1 | |
| SCHEMBL3682641 | 0.85 | LMNA (0.47) | LMNAPOLBTDP1TSHRMEN1 | |
| SCHEMBL3678630 | 0.83 | LMNA (0.54) | LMNAPOLBTDP1TSHRMEN1 | |
| SCHEMBL3678627 | 0.83 | LMNA (0.54) | LMNAPOLBTDP1TSHRMEN1 | |
| SCHEMBL1150268 | 0.82 | LMNA (0.69) | LMNATDP1TSHRMEN1KMT2A | |
| SCHEMBL11291535 | 0.82 | LMNA (0.69) | LMNATDP1TSHRMEN1KMT2A | |
| SCHEMBL10952942 | 0.82 | LMNA (0.69) | LMNATDP1TSHRMEN1KMT2A | |
| SCHEMBL358792 | 0.82 | LMNA (0.69) | LMNATDP1TSHRMEN1KMT2A | |
| SCHEMBL1150270 | 0.82 | LMNA (0.69) | LMNATDP1TSHRMEN1KMT2A | |
| SCHEMBL359355 | 0.79 | LMNA (0.51) | LMNATDP1TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2412702-B1 | METHOD FOR PRODUCING CYCLOPROPANECARBOXYLIC ACID ESTER | SUMITOMO CHEMICAL CO (JP) | 2014-12-03 | — | — | EP | disclosed |
| US-20120029227-A1 | METHOD FOR PRODUCING CYCLOPROPANECARBOXYLIC ACID ESTER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-02-02 | — | — | US | disclosed |
| EP-2412702-A1 | METHOD FOR PRODUCING CYCLOPROPANECARBOXYLIC ACID ESTER | Sumitomo Chemical Company, Limited (JP) | 2012-02-01 | — | — | EP | disclosed |
| US-7700799-B2 | Method for producing (2-formyl-1-alkenyl) cyclopropane compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-20 | — | — | US | disclosed |
| EP-1731564-B1 | Water tree retarding composition | BOREALIS TECH OY (FI) | 2010-03-10 | — | — | EP | disclosed |
| US-20090137839-A1 | METHOD FOR PRODUCING (2-FORMYL-1-ALKENYL) CYCLOPROPANE COMPOUND | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2009-05-28 | — | — | US | disclosed |
| US-7498459-B2 | Method for producing (1-alkenyl)cyclopropane compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-03-03 | — | — | US | disclosed |
| US-20070197818-A1 | Method for producing (1-alkenyl) cyclopropane compound | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-08-23 | — | — | US | disclosed |
| WO-2006131266-A1 | WATER TREE RETARDING COMPOSITION | BOREALIS TECHNOLOGY OY (FI) | 2006-12-14 | — | — | WO | disclosed |
| EP-1731564-A1 | Water tree retarding composition | Borealis Technology Oy (FI) | 2006-12-13 | — | — | EP | disclosed |
| EP-1728781-A1 | PROCESS FOR PRODUCTION OF (1-ALKENYL)CYCLOPROPANES | Sumitomo Chemical Company, Limited (JP) | 2006-12-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029227-A1 | METHOD FOR PRODUCING CYCLOPROPANECARBOXYLIC ACID ESTER | PCCA, COASY, GRHPR | LMNA 1488/4885POLB 2404/4885TDP1 4158/4885 |
| US-20090137839-A1 | METHOD FOR PRODUCING (2-FORMYL-1-ALKENYL) CYCLOPROPANE COMPOUND | ACSL3, ACSL1, ARL1 | LMNA 2696/4885POLB 2007/4885TDP1 4458/4885 |
| US-20070197818-A1 | Method for producing (1-alkenyl) cyclopropane compound | ACSL3, ARL1, ACSL1 | LMNA 3763/4885POLB 2766/4885TDP1 4490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.